Eton Pharmaceuticals Inc (ETON) — Capital Reinvestment Ratio
Latest as of March 2026:
0.01x
Eton Pharmaceuticals Inc (ETON) has a Capital Reinvestment Ratio of 0.01x as of March 2026, meaning it reinvests 0% of its operating cash flow ($7.41 Million) in capital expenditures ($75.00K). See ETON free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$7.41 Million
USD
Capital Expenditures
$75.00K
USD
Data as of
Mar 2026
Most recent filing
Eton Pharmaceuticals Inc Capital Reinvestment Ratio (2022–2025)
This chart tracks Eton Pharmaceuticals Inc's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Eton Pharmaceuticals Inc (2022–2025)
Year-by-year Capital Reinvestment Ratio for Eton Pharmaceuticals Inc from 2022 to 2025. For live market cap and broader valuation context, see ETON market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $10.52 Million | $333.00K | ▲ +17.9% |
| 2024 | 0.03x | $969.00K | $26.00K | ▼ -76.4% |
| 2023 | 0.11x | $6.82 Million | $775.00K | ▼ -80.3% |
| 2022 | 0.58x | $4.82 Million | $2.79 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow